113 related articles for article (PubMed ID: 15330266)
1. Activities of synthetic peptides against human pathogenic bacteria.
Bogucka K; Królicka A; Kamysz W; Ossowski T; Lukasiak J; Lojkowska E
Pol J Microbiol; 2004; 53(1):41-4. PubMed ID: 15330266
[TBL] [Abstract][Full Text] [Related]
2. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
3. Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability.
Oh H; Hedberg M; Wade D; Edlund C
Antimicrob Agents Chemother; 2000 Jan; 44(1):68-72. PubMed ID: 10602725
[TBL] [Abstract][Full Text] [Related]
4. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
5. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
[TBL] [Abstract][Full Text] [Related]
7. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.
Wade D; Andreu D; Mitchell SA; Silveira AM; Boman A; Boman HG; Merrifield RB
Int J Pept Protein Res; 1992 Nov; 40(5):429-36. PubMed ID: 1483838
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.
Boman HG; Wade D; Boman IA; Wåhlin B; Merrifield RB
FEBS Lett; 1989 Dec; 259(1):103-6. PubMed ID: 2689223
[TBL] [Abstract][Full Text] [Related]
10. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
12. Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii.
Saugar JM; Alarcón T; López-Hernández S; López-Brea M; Andreu D; Rivas L
Antimicrob Agents Chemother; 2002 Mar; 46(3):875-8. PubMed ID: 11850277
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains.
Alarcón T; López-Hernández S; Andreu D; Saugar JM; Rivas L; López-Brea M
Rev Esp Quimioter; 2001 Jun; 14(2):184-90. PubMed ID: 11704773
[TBL] [Abstract][Full Text] [Related]
14. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
[TBL] [Abstract][Full Text] [Related]
16. Exploring Galleria mellonella larval model to evaluate antibacterial efficacy of Cecropin A (1-7)-Melittin against multi-drug resistant enteroaggregative Escherichia coli.
Vergis J; Malik SVS; Pathak R; Kumar M; Kurkure NV; Barbuddhe SB; Rawool DB
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33512501
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin.
Bucki R; Pastore JJ; Randhawa P; Vegners R; Weiner DJ; Janmey PA
Antimicrob Agents Chemother; 2004 May; 48(5):1526-33. PubMed ID: 15105101
[TBL] [Abstract][Full Text] [Related]
19. A novel antimicrobial protein for plant protection consisting of a Xanthomonas oryzae harpin and active domains of cecropin A and melittin.
Che YZ; Li YR; Zou HS; Zou LF; Zhang B; Chen GY
Microb Biotechnol; 2011 Nov; 4(6):777-93. PubMed ID: 21895994
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Jeong N; Kim JY; Park SC; Lee JK; Gopal R; Yoo S; Son BK; Hahm JS; Park Y; Hahm KS
Biochem Biophys Res Commun; 2010 Sep; 399(4):581-6. PubMed ID: 20682287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
